---
title: "Trust issues"
image: "https:\/\/i.ytimg.com\/vi\/M8SQCDIVf1s\/hqdefault.jpg"
vid_id: "M8SQCDIVf1s"
categories: "Education"
tags: ["physiology","nursing","NCLEX"]
date: "2021-10-14T13:35:55+03:00"
vid_date: "2021-10-13T20:54:08Z"
duration: "PT24M42S"
viewcount: "103959"
likeCount: "4681"
dislikeCount: "403"
channel: "Dr. John Campbell"
---
{% raw %}Is there a crisis of trust?<br /><br /><a rel="nofollow" target="blank" href="https://ourworldindata.org/coronavirus">https://ourworldindata.org/coronavirus</a><br /><br />John's free textbooks<br /><br />Download my two comprehensive but free educational text books or make a donation to the campbellteaching project using this link: <a rel="nofollow" target="blank" href="http://159.69.48.3Russia">http://159.69.48.3Russia</a><br /><br /><a rel="nofollow" target="blank" href="https://www.youtube.com/watch?v=ijgNJpUes4Y">https://www.youtube.com/watch?v=ijgNJpUes4Y</a><br /><br /><a rel="nofollow" target="blank" href="https://www.dailymail.co.uk/news/article-10084049/Video-showing-Putin-coughing-meeting-emerges-forced-deny-having-Covid-19.html">https://www.dailymail.co.uk/news/article-10084049/Video-showing-Putin-coughing-meeting-emerges-forced-deny-having-Covid-19.html</a><br /><br />Infections, + 29,409<br /><br />Deaths, + 973 = 217,000<br /><br />Delta variant<br /><br />Vaccine hesitancy<br /><br />First dose, 33%<br /><br />Rolled out before trials<br /><br />Problem is not that bad<br /><br />Government had won the war on covid-19<br /><br />Mr. Putin pulls out of G20 meeting due to 'diary clash'<br /><br />Two doses of Sputnik V<br /><br />ITU, 8,000 patients<br /><br />Patients becoming critical in 3 to 4 days<br /><br />Vaccination passports cost 70 euros<br /><br />Widespread public misconceptions<br /><br />Hygiene rules hardly followed<br /><br />Limited restrictions<br /><br />Limited mask wearing<br /><br />Official information not believed<br /><br />Indian summer just now<br /><br />Moscow may well cope<br /><br />New infectious disease hospital<br /><br />Regions, hospitals already full<br /><br />Molnupiravir, Merck, awaiting EMU<br /><br />US government at $700 (£515) per course<br /><br />Analysts at Harvard School of Public Health and King's College Hospital in London have found it costs just $17.74 (£13) to produce.<br /><br />Despite this, Merck and Ridgeback could earn $7 billion in profits by the end of the year.<br /><br /><a rel="nofollow" target="blank" href="https://news.sky.com/story/covid-news-uk-latest-live-experts-discover-why-people-get-covid-toes-as-wales-introduces-vaccine-passports-12425651">https://news.sky.com/story/covid-news-uk-latest-live-experts-discover-why-people-get-covid-toes-as-wales-introduces-vaccine-passports-12425651</a><br /><br /><a rel="nofollow" target="blank" href="https://www.fiercepharma.com/pharma/merck-molnupiravir-blockbuster-covid-19-pandemic-endemic-oral-antivirals-market">https://www.fiercepharma.com/pharma/merck-molnupiravir-blockbuster-covid-19-pandemic-endemic-oral-antivirals-market</a><br /><br />That’s about $700 per course. Merck said it expects to make 10 million courses of the drug by the end of 2021, meaning $7 billion in revenue<br /><br /><br /><br /><br />BBC Media Action<br /> <br /><br />£1,569,000 in 2019 - 2020<br /><br /><a rel="nofollow" target="blank" href="https://www.bbc.co.uk/mediaaction/about/funding">https://www.bbc.co.uk/mediaaction/about/funding</a><br /><br /><a rel="nofollow" target="blank" href="https://www.bbc.co.uk/mediaaction/about/annual-reports">https://www.bbc.co.uk/mediaaction/about/annual-reports</a><br /><br /><a rel="nofollow" target="blank" href="https://www.bbc.co.uk/mediaaction/where-we-work">https://www.bbc.co.uk/mediaaction/where-we-work</a><br /> <br />We support the independent media essential to democracy and development. <br /><br />We inform, connect and inspire change in our audiences, providing trusted information, stories and ideas that generate discussion and bridge divides.<br /><br />helping to save lives and improve health, protect livelihoods, challenge inequality and build more peaceful and democratic societies.<br /><br />Coronavirus: lessons learned to date <br /><br /><a rel="nofollow" target="blank" href="https://committees.parliament.uk/publications/7496/documents/78687/default/">https://committees.parliament.uk/publications/7496/documents/78687/default/</a><br /><br />in 2020 the UK did significantly worse in terms of covid deaths than many countries—especially compared to those in East Asia<br /><br />The UK’s pandemic planning was too narrowly and inflexibly based on a flu model which failed to learn the lessons from SARS, MERS and Ebola. <br /><br />In the first three months the strategy reflected official scientific advice to the Government which was accepted and implemented. <br /><br />When the Government moved from the ‘contain’ stage to the ‘delay’ stage, <br /><br />that approach involved trying to manage the spread of covid through the population rather than to stop it spreading altogether. <br /><br />This amounted in practice to accepting that herd immunity by infection was the inevitable outcome, <br /><br />The UK, along with many other countries in Europe and North America made a serious early error in adopting this fatalistic approach <br /><br />and not considering a more emphatic and rigorous approach to stopping the spread of the virus as adopted by many East and South East Asian countries. <br /><br />The fact that the UK approach reflected a consensus between official scientific advisers and the Government indicates a degree of groupthink <br /><br />that was present at the time which meant we were not as open to approaches being taken elsewhere as we should have been.{% endraw %}
